[Transluminal balloon angioplasty in treatment of lower limb critical ischaemia].
Currently, there is no doubt that transluminal balloon angioplasty (TLBAP) is a method of choice in treatment of patients suffering from lower limb critical ischaemia (LLCI) either accompanied by severe pathology or associated with low life expectancy, as well as under the circumstances rendering no anatomical conditions for performing a by-pass grafting operation. However, it is necessary to perform a repeat scrutiny of the comparative outcomes of endovascular and surgical management of LLCI in those patients equally eligible for either method of revascularization with due regard for the present-day possibilities of TLBAP.